Ozempic has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease, drugmaker Novo Nordisk said Tuesday. 24/7 Live Raleigh ...

Ozempic, the GLP-1 drug initially approved by the FDA to treat type 2 diabetes, was recently OK'd to also help reduce risks linked to chronic kidney disease.

March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in 2025, the U.S. Food and Drug Administration (FDA) approved Ozempic ...

Chronic kidney disease is a common complication of type 2 diabetes; around 40% of people with type 2 diabetes also experience CKD. The FDA's decision was supported by the phase IIIb FLOW trial of ...

It also reduced the risk of kidney failure and cut the risk of death from heart disease by about 5% in adults with both type 2 diabetes and chronic kidney disease, the company said in a news release.

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks ...